Finance

Lists
6CQ:FRA
Cresco Labs Inc
€0.66
+0.46%
(+0.0030) 1D
Sep 23, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6CQ...
Open
€0.66
High
€0.66
Low
€0.66
Mkt. cap
389.62M
Avg. vol.
580.00
Volume
0.00
52-wk high
€1.90
52-wk low
€0.53
No. of employees
3K
Open
€0.66
High
€0.66
Low
€0.66
Mkt. cap
389.62M
Avg. vol.
580.00
Volume
0.00
52-wk high
€1.90
52-wk low
€0.53
No. of employees
3K
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2.9K
Founded2013
HeadquartersChicago, Illinois, United States
SectorPharmaceutical industry
Websitecrescolabs.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
164.91M
161.55M
151.32M
173.34M
Cost of goods sold
85.55M
78.23M
75.88M
86.39M
Cost of revenue
85.55M
78.23M
75.88M
86.39M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53.53M
60.43M
59.36M
66.63M
Operating expense
59.17M
65.40M
64.28M
73.59M
Total operating expenses
144.72M
143.63M
140.15M
159.98M
Operating income
20.19M
17.92M
11.17M
13.36M
Other non operating income
4.21M
4.23M
1.34M
-233.00K
EBT including unusual items
-10.10M
-87.15M
-2.79M
-3.60M
EBT excluding unusual items
10.06M
7.62M
-2.75M
-1.76M
Income tax expense
11.87M
1.80M
14.22M
-18.97M
Effective tax rate
-117.48%
-2.07%
-508.95%
527.42%
Other operating expenses
-
-
-
-
Net income
-17.05M
-87.59M
-13.07M
16.80M
Net profit margin
-10.34%
-54.22%
-8.64%
9.69%
Earnings per share
0.01
-0.03
-0.04
0.06
Interest and investment income
699.00K
1.30M
407.00K
407.00K
Interest expense
-15.27M
-15.63M
-15.33M
-15.51M
Net interest expenses
-14.57M
-14.33M
-14.93M
-15.10M
Depreciation and amortization charges
5.64M
4.97M
4.92M
6.96M
EBITDA
33.05M
28.68M
23.39M
26.02M
Gain or loss from assets sale
-2.60M
352.00K
-
1.93M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps